Malignant neoplasm of broad ligament
ICD-10 C57.1 is a billable code used to indicate a diagnosis of malignant neoplasm of broad ligament.
Malignant neoplasm of the broad ligament is a rare gynecologic malignancy that arises from the connective tissue of the broad ligament, which is a peritoneal fold that supports the uterus, ovaries, and fallopian tubes. This neoplasm can present as a mass in the pelvic region and may be associated with symptoms such as abdominal pain, abnormal bleeding, or urinary symptoms. Diagnosis typically involves imaging studies such as ultrasound or MRI, and histological confirmation through biopsy. The staging of this malignancy follows the FIGO (International Federation of Gynecology and Obstetrics) staging system, which assesses the extent of the tumor, lymph node involvement, and distant metastasis. CA-125, a tumor marker, may be elevated in patients with this condition, although it is not specific to broad ligament tumors. Treatment often involves surgical resection, which may include a hysterectomy and removal of affected tissues, followed by adjuvant therapies such as chemotherapy or radiation, depending on the stage and histological type of the tumor.
Detailed operative reports, pathology reports, imaging studies, and follow-up notes are essential for accurate coding.
Diagnosis and treatment planning for patients presenting with pelvic masses, staging evaluations, and post-operative follow-ups.
Accurate staging and documentation of surgical interventions are critical for appropriate coding and reimbursement.
Clear imaging reports that specify findings related to the broad ligament and any associated structures.
Imaging studies for suspected malignancies, follow-up imaging post-surgery, and evaluation of treatment response.
Radiologists must ensure that imaging findings are clearly correlated with clinical diagnoses to support coding.
Used for surgical treatment of malignant neoplasm of the broad ligament.
Operative report detailing the procedure and findings.
Gynecologic oncologists must ensure comprehensive documentation of tumor characteristics.
Common symptoms include pelvic pain, abnormal vaginal bleeding, and urinary symptoms. Patients may also present with a palpable mass.
Staging for C57.1 follows the FIGO system, which assesses tumor size, lymph node involvement, and distant metastasis.
CA-125 is a tumor marker that may be elevated in patients with malignant neoplasms of the broad ligament, but it is not specific to this condition.
Common surgical procedures include total abdominal hysterectomy and possible lymphadenectomy, depending on the extent of the disease.
